查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
HLA 分型市场规模、份额、趋势分析报告：按产品（试剂/耗材、软件/服务）、技术、应用（诊断、研究）、最终用户、地区、细分市场，2023-2030 年
市场调查报告书
商品编码
1171082

HLA 分型市场规模、份额、趋势分析报告：按产品（试剂/耗材、软件/服务）、技术、应用（诊断、研究）、最终用户、地区、细分市场，2023-2030 年

HLA Typing Market Size, Share & Trends Analysis Report By Product (Reagents & Consumables, Software & Services), By Technique, By Application (Diagnosis, Research), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

HLA 分型市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，HLA 分型的全球市场预计到 2030 年将达到 17 亿美元。 从 2023 年到 2030 年，该市场预计将以 6.7% 的复合年增长率增长。 干细胞移植的兴起以及人类白细胞抗原 (HLA) 分型在其他应用中的广泛使用预计将支持市场增长。 从 2016 年到 2020 年，美国大约进行了 111,984 例造血细胞移植，其中 89% 的细胞来源来自外周血，9% 来自骨髓，2% 来自脐带血。 同样，该地区拥有超过 219 个进行造血细胞移植的设施。

HLA 分型有望成为各种基础和转化研究的宝贵资源。 这是因为某些 HLA 等位基因会影响严重程度和对感染的易感性，而其他等位基因则与自身免疫性疾病和癌症等疾病的多种遗传易感性有关。 . 深入了解哪些单倍型更有可能发展为严重疾病或预后较差，这对于药物开发的转化应用特别有用。 因此，预计将 HLA 分型用于研究应用将对整体市场估计做出重大贡献。

COVID-19 大流行对市场产生了负面影响。 少数研究人员提出了将 HLA 分型与 COVID-19 检测相结合的概念。 例如，2021 年 8 月，发表在《欧洲医学研究杂誌》上的一项研究的科学证据表明，临床试验应包括 HLA 结合，并将其与 COVID-19 检测相结合，以加快识别人群中的预测因子。

预计公司不断增加的战略举措将推动市场的增长。 例如，2022年3月，Immucor, Inc.宣布推出HLA分型软件，作为HLA分型检测的配套产品。 该软件有望成为用户节省成本的选择，并使 NGS 分析过程更加轻鬆快捷。

另一方面，越来越多的受者被从器官移植等候名单中剔除，将影响HLA分型的利用。 从名单中删除的原因包括患者病情恶化、患者死亡和疾病康復。 例如，从2021年1月到2021年12月，巴恩斯犹太医院有6名患者死于器官短缺，11名患者病情恶化。

HLA 打字市场报告要点

按产品划分，预计试剂耗材部分将在预测期内实现最快的增长率。 现有参与者的产品开发正在加紧进行，以扩大 HLA 分型在免疫治疗等各个研究领域的应用。

从应用来看，诊断领域有望在2022年呈现出最快的增长速度，并占据更大的份额。 它已被证明是器官移植和传染病上升的重要信息来源，从而促进了市场的增长。

就技术而言，基于测序的分子检测部分预计在 2023 年至 2030 年期间的复合年增长率最快。 这是因为它在单个测定中提供了明确的相分离 HLA 分型。

按最终用户划分，医院和移植中心部分预计将在 2022 年占据大部分市场份额。 这是因为发达国家拥有装备精良的研究设施

北美以 46.94% 的总市场份额巩固了其区域地位。 这是由于移植中心和诊所的存在，以及该地区主要参与者的存在。

内容

第一章研究方法论

  • 按国家/地区划分的市场：基本估计
  • 全球市场：CAGR 计算
  • 按地区计算细分市场份额
  • 调查范围和假设
  • 数据源列表
    • 来自主要访谈的数据（按来源）
    • 按地区划分的首次访谈数据

第 2 章执行摘要

  • 市场概况

第 3 章 HLA 分型市场变量、趋势和范围

  • 市场细分和范围
  • 市场驱动因素分析
    • 增加器官移植
    • 测试技术的技术进步
    • 在药物遗传学中采用 HLA 检测
  • 市场製约因素分析
    • 严格的监管框架
  • HLA 分类 - SWOT 分析，按因素（政治和法律、经济、技术）
  • 行业分析 - 搬运工
  • HLA 打字市场：2022 年市场分析
  • COVID-19 影响分析

第 4 章 HLA 分型市场：按产品分类的估计和趋势分析

  • HLA 分型市场：按产品分类的变化分析
  • 仪器
    • 乐器市场
  • 试剂和耗材
    • 试剂和耗材市场
  • 软件和服务
    • 软件和服务市场

第 5 章 HLA 分型市场：应用的估计和趋势分析

  • HLA 分型市场：按应用进行的变化分析
  • 诊断
    • 诊断市场
  • 调查
    • 研究市场

第 6 章 HLA 分型市场：按技术估算和趋势分析

  • HLA 分型市场：技术变化分析
  • 分子检测
    • 分子检测市场
  • 基于序列的分子检测
    • 基于序列的分子检测市场
  • 非分子检测
    • 非分子检测市场

第 7 章 HLA 分型市场：最终用户的估计和趋势分析

  • HLA 打字市场：最终用户的变化分析
  • 商业服务提供商
    • 商业服务提供商市场
  • 医院和移植中心
    • 医院和移植中心市场
  • 研究和学术机构
    • 研究和学术机构市场

第 8 章 HLA 分型市场：按产品、应用、技术和最终用途分类的区域估计和趋势分析

  • 2022 年和 2030 年各地区 HLA 分型市场份额
  • 北美
    • SWOT 分析
      • 2022 年和 2030 年按产品分列的北美 HLA 分型市场份额
      • 北美 HLA 分型市场，按应用分类
      • 北美 HLA 分型市场，按最终用户分类
      • 北美 HLA 分型市场，按技术分类
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 美国 HLA 分型市场，按产品分类
      • 美国 HLA 分型市场，按应用分类
      • 美国 HLA 分型市场，按最终用户分类
      • 美国 HLA 分型市场，按技术分类
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 加拿大 HLA 分型市场，按产品分类
      • 加拿大 HLA 分型市场，按应用分类
      • 加拿大 HLA 分型市场，按最终用户分类
      • 加拿大 HLA 分型市场，按技术分类
  • 欧洲
    • SWOT 分析
      • 欧洲 HLA 分型市场，按产品分类
      • 欧洲 HLA 分型市场，按应用分类
      • 欧洲 HLA 分型市场，按最终用户分类
      • 欧洲 HLA 分型市场，按技术分类
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 德国 HLA 分型市场，按产品分类
      • 德国 HLA 分型市场，按应用分类
      • 德国 HLA 类型市场，按最终用户分类
      • 德国 HLA 分型市场，按技术分类
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 英国 HLA 分型市场，按产品分类
      • 英国 HLA 分型市场，按应用分类
      • 英国 HLA 打字市场，按最终用户分类
      • 英国 HLA 分型市场，按技术分类
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 法国 HLA 分型市场，按产品
      • 法国 HLA 分型市场，按应用分类
      • 法国 HLA 分型市场，按最终用户分类
      • 法国 HLA 分型市场，按技术分类
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 意大利 HLA 分型市场，按产品分类
      • 意大利 HLA 分型市场，按应用分类
      • 意大利 HLA 打字市场，按最终用户分类
      • 意大利 HLA 分型市场，按技术分类
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 西班牙 HLA 分型市场，按产品分类
      • 西班牙 HLA 分型市场，按应用分类
      • 西班牙 HLA 打字市场，按最终用户分类
      • 西班牙 HLA 分型市场，按技术分类
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 丹麦 HLA 分型市场，按产品
      • 丹麦 HLA 分型市场，按应用分类
      • 丹麦 HLA 打字市场，按最终用户分类
      • 丹麦 HLA 分型市场，按技术分类
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 瑞典 HLA 分型市场，按产品分类
      • 瑞典 HLA 分型市场，按应用分类
      • 瑞典 HLA 分型市场，按最终用户分类
      • 瑞典 HLA 分型市场，按技术分类
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 挪威 HLA 分型市场，按产品分类
      • 挪威 HLA 分型市场，按应用分类
      • 挪威 HLA 打字市场，按最终用户分类
      • 挪威 HLA 分型市场，按技术分类
  • 亚太地区
    • SWOT 分析
      • 亚太地区 HLA 分型市场，按产品分类
      • 亚太地区 HLA 分型市场，按应用分类
      • 亚太地区 HLA 打字市场，按最终用户分类
      • 亚太地区 HLA 分型市场，按技术分类
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 日本 HLA 分型市场，按产品
      • 日本 HLA 分型市场，按应用分类
      • 日本 HLA 分型市场，按最终用户分类
      • 日本 HLA 分型市场，按技术分类
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 中国 HLA 分型市场，按产品分类
      • 中国 HLA 分型市场，按应用分类
      • 中国 HLA 分型市场，按最终用户分类
      • 中国的 HLA 分型市场，按技术分类
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 印度 HLA 分型市场，按产品分类
      • 印度 HLA 分型市场，按应用分类
      • 印度 HLA 分型市场，按最终用户分类
      • 印度 HLA 分型市场，按技术分类
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 韩国 HLA 分型市场，按产品分类
      • 韩国 HLA 分型市场，按应用分类
      • 韩国 HLA 打字市场，按最终用户分类
      • 韩国 HLA 分型市场，按技术分类
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 澳大利亚 HLA 分型市场，按产品分类
      • 澳大利亚 HLA 分型市场，按应用分类
      • 澳大利亚 HLA 分型市场，按最终用户分类
      • 澳大利亚 HLA 分型市场，按技术分类
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 泰国 HLA 分型市场，按产品
      • 泰国的 HLA 分型市场，按应用分类
      • 泰国 HLA 打字市场，按最终用户分类
      • 泰国 HLA 分型市场，按技术分类
  • 拉丁美洲
    • SWOT 分析
      • 拉丁美洲 HLA 分型市场，副产品
      • 拉丁美洲 HLA 分型市场，按应用分类
      • 拉丁美洲 HLA 类型市场，按最终用户分类
      • 拉丁美洲 HLA 分型市场，按技术分类
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 巴西 HLA 分型市场，副产品
      • 巴西 HLA 分型市场，按应用分类
      • 巴西 HLA 打字市场，按最终用户分类
      • 巴西 HLA 分型市场，按技术分类
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 墨西哥 HLA 分型市场，按产品分类
      • 墨西哥 HLA 分型市场，按应用分类
      • 墨西哥 HLA 打字市场，按最终用户分类
      • 墨西哥 HLA 分型市场，按技术分类
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 阿根廷 HLA 分型市场，按产品分类
      • 阿根廷 HLA 分型市场，按应用分类
      • 阿根廷 HLA 打字市场，按最终用户分类
      • 阿根廷 HLA 分型市场，按技术分类
  • 多边环境协定
    • SWOT 分析
      • MEA HLA 分型市场，按产品分类
      • MEA HLA 分型市场，按应用分类
      • MEA HLA 打字市场，按最终用户分类
      • MEA HLA 分型市场，按技术分类
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 南非 HLA 分型市场，按产品分类
      • 南非 HLA 分型市场，按应用分类
      • 南非 HLA 分型市场，按最终用户分类
      • 南非 HLA 分型市场，按技术分类
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 沙特阿拉伯 HLA 分型市场，副产品
      • 沙特阿拉伯 HLA 分型市场，按应用分类
      • 沙特阿拉伯 HLA 打字市场，按最终用户分类
      • 沙特阿拉伯 HLA 分型市场，按技术分类
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 阿拉伯联合酋长国 HLA 分型市场，按产品分类
      • 阿拉伯联合酋长国 HLA 分型市场，按应用分类
      • 阿拉伯联合酋长国 HLA 打字市场，按最终用户分类
      • 阿拉伯联合酋长国 HLA 分型市场，按技术分类
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
      • 科威特 HLA 分型市场，副产品
      • 科威特 HLA 分型市场，按应用分类
      • 科威特 HLA 打字市场，按最终用户分类
      • 科威特 HLA 分型市场，按技术分类

第9章竞争格局

  • Participant's overview
  • Financial performance
  • 参与者分类
    • 市场领导者
      • 2022 年 HLA 打字市场份额分析
      • 公司简介
      • Thermo Fisher Scientific Inc.
      • Bio-Rad Laboratories Inc.
      • Qiagen N.V.
      • Omixon Inc.
      • GenDx
      • Illumina Inc.
      • TBG Diagnostics Limited
      • Dickinson and Company
      • Takara Bio Inc.
      • F. Hoffman-La Roche Limited
      • Pacific Biosciences
    • 战略规划
      • 分机
      • 得到
      • 协作
      • 产品/服务发布
      • 伙伴关係
      • 其他
Product Code: GVR-4-68040-007-6

HLA Typing Market Growth & Trends:

The global HLA typing market size is expected to reach USD 1.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2023 to 2030. The increasing stem cell transplantation coupled with expanding the use of human leukocyte antigen (HLA) typing in other applications is expected to support the growth of the market. From 2016 to 2020, around 111,984 hematopoietic cell transplantations were performed in the U.S. Out of those, 89% of cell sources were peripheral blood, 9% were from bone marrow and 2% were from cord blood. Similarly, there are over 219 centers in the region for performing hematopoietic cell transplantations.

HLA typing is expected to be a valuable source of information for various basic and translational research studies. Since some HLA alleles can impact the severity and susceptibility of infectious diseases, while other HLA alleles are related to the diverse predispositions of genetics to diseases such as autoimmune conditions and cancer. Gaining insights into which haplotypes can have a higher probability of critical disease or poor prognosis can be specifically useful in translational applications for developing therapeutics. Hence, HLA typing usage in research applications is expected to have a considerable contribution to the overall market estimates.

The COVID-19 pandemic adversely impacted the market. Although there was a handful of researchers with the concept of integrating HLA typing with COVID-19 testing. For instance, in August 2021, the scientific evidence from research published in the European Journal of Medical Research suggested including HLA tying in clinical trials and combining it with the COVID-19 test to increase the speed of identifying a predictor in the population.

The growing strategic initiatives by the companies are anticipated to boost market growth. For instance, in March 2022, Immucor, Inc. announced to launch a HLA typing software as a supporting product for its HLA typing assay. The software is expected to ease and quicker the NGS analysis process with a cost-saving option for the users.

On the other hand, the increasing number of recipients removed from the waiting list for organ transplantation is likely to affect the usage of HLA typing. The reasons for the removal from the list are deterioration in the patient's condition, patient's death, or recovery from the disease. For instance, from January 2021 to December 2021, 6 patients from Barnes-Jewish Hospital died due to the shortage of organs, while 11 patients' conditions deteriorated.

HLA Typing Market Report Highlights:

  • By product, the reagents consumables segment is projected to establish the fastest growth rate over the forecast period. Since increasing product development by the existing players to expand the usage of HLA typing in various fields of research, such as immunotherapies
  • By application, the diagnosis segment is anticipated to have the fastest growth rate with a larger share in 2022. Owing to the increase in organ transplantations and showcasing evidence of being an important source of information for infectious diseases, hence, propelling market growth
  • By technique, the sequenced-based molecular assay segment is anticipated to have the fastest CAGR between 2023 to 2030. Since, it has the ability to generate clear, phase-resolved HLA typing with a single assay
  • By end-user, the hospitals and transplant centers segment is projected to have a majority of the market share in 2022. This is attributed to the presence of well-equipped facilities for research in developed countries
  • North America has strengthened its regional position in the market with 46.94% of the overall market share. This is attributed to the presence of transplant centers and clinics, along with the existence of key players in the region

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources
    • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 HLA typing Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing number of organs transplants
    • 3.2.2 Technology advancement in testing techniques
    • 3.2.3 Adoption of HLA testing in Pharmacogenetic
  • 3.3 Market Restraint Analysis
    • 3.3.1 Stringent Regulatory Framework
  • 3.4 HLA typing - SWOT Analysis, By Factor (political & legal, economic, and technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 HLA Typing Market: Market Position Analysis, 2022
  • 3.7 COVID-19 Impact Analysis

Chapter 4 HLA Typing Market: Product Estimates & Trend Analysis

  • 4.1 HLA Typing Market: Product Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments market
  • 4.3 Reagents & consumables
    • 4.3.1 Reagents & consumables market
  • 4.4 Software & Services
    • 4.4.1 Software & services market

Chapter 5 HLA Typing Market: Application Estimates & Trend Analysis

  • 5.1 HLA Typing Market: Application Movement Analysis
  • 5.2 Diagnosis
    • 5.2.1 Diagnosis market
  • 5.3 Research
    • 5.3.1 Research market

Chapter 6 HLA Typing Market: Technique Estimates & Trend Analysis

  • 6.1 HLA Typing Market: Technique Movement Analysis
  • 6.2 Molecular Assay
    • 6.2.1 Molecular assay market
  • 6.3 Sequenced-based Molecular Assay
    • 6.3.1 Sequenced-based molecular assay market
  • 6.4 Non-Molecular Assay
    • 6.4.1 Non-molecular assay Market

Chapter 7 HLA Typing Market: End-user Estimates & Trend Analysis

  • 7.1 HLA Typing Market: End-user Movement Analysis
  • 7.2 Commercial Service Providers
    • 7.2.1 Commercial service providers market
  • 7.3 Hospitals and Transplant Centers
    • 7.3.1 Hospitals and transplant centers market
  • 7.4 Research Labs & Academic Institutes
    • 7.4.1 Research labs & academic institutes market

Chapter 8 HLA typing Market: Regional Estimates & Trend Analysis, by Product, Application, Technique, End-use

  • 8.1 HLA typing Market Share By Region, 2022 & 2030
  • 8.2 North America
    • 8.2.1 SWOT Analysis
      • 8.2.1.1 North America HLA typing market, by product
      • 8.2.1.2 North America HLA typing market, by application
      • 8.2.1.3 North America HLA typing market, by End-user
      • 8.2.1.4 North America HLA typing market, by technique
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 Target Disease Prevalence
      • 8.2.2.3 Competitive Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
      • 8.2.2.6 U.S. HLA typing market, by product
      • 8.2.2.7 U.S. HLA typing market, by application
      • 8.2.2.8 U.S. HLA typing market, by End-user
      • 8.2.2.9 U.S. HLA typing market, by technique
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Target Disease Prevalence
      • 8.2.3.3 Competitive Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
      • 8.2.3.6 Canada HLA typing market, by product
      • 8.2.3.7 Canada HLA typing market, by application
      • 8.2.3.8 Canada HLA typing market, by End-user
      • 8.2.3.9 Canada HLA typing market, by technique
  • 8.3 Europe
    • 8.3.1 SWOT Analysis
      • 8.3.1.1 Europe HLA typing market, by product
      • 8.3.1.2 Europe HLA typing market, by application
      • 8.3.1.3 Europe HLA typing market, by End-user
      • 8.3.1.4 Europe HLA typing market, by technique
    • 8.3.2 Germany
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Target Disease Prevalence
      • 8.3.2.3 Competitive Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
      • 8.3.2.6 Germany HLA typing market, by product
      • 8.3.2.7 Germany HLA typing market, by application
      • 8.3.2.8 Germany HLA typing market, by End-user
      • 8.3.2.9 Germany HLA typing market, by technique
    • 8.3.3 UK
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Target Disease Prevalence
      • 8.3.3.3 Competitive Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
      • 8.3.3.6 UK HLA typing market, by product
      • 8.3.3.7 UK HLA typing market, by application
      • 8.3.3.8 UK HLA typing market, by End-user
      • 8.3.3.9 UK HLA typing market, by technique
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 Target Disease Prevalence
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
      • 8.3.4.6 France HLA typing market, by product
      • 8.3.4.7 France HLA typing market, by application
      • 8.3.4.8 France HLA typing market, by End-user
      • 8.3.4.9 France HLA typing market, by technique
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Target Disease Prevalence
      • 8.3.5.3 Competitive Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
      • 8.3.5.6 Italy HLA typing market, by product
      • 8.3.5.7 Italy HLA typing market, by application
      • 8.3.5.8 Italy HLA typing market, by End-user
      • 8.3.5.9 Italy HLA typing market, by technique
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Target Disease Prevalence
      • 8.3.6.3 Competitive Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
      • 8.3.6.6 Spain HLA typing market, by product
      • 8.3.6.7 Spain HLA typing market, by application
      • 8.3.6.8 Spain HLA typing market, by End-user
      • 8.3.6.9 Spain HLA typing market, by technique
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Target Disease Prevalence
      • 8.3.7.3 Competitive Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
      • 8.3.7.6 Denmark HLA typing market, by product
      • 8.3.7.7 Denmark HLA typing market, by application
      • 8.3.7.8 Denmark HLA typing market, by End-user
      • 8.3.7.9 Denmark HLA typing market, by technique
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Target Disease Prevalence
      • 8.3.8.3 Competitive Scenario
      • 8.3.8.4 Regulatory Framework
      • 8.3.8.5 Reimbursement Scenario
      • 8.3.8.6 Sweden HLA typing market, by product
      • 8.3.8.7 Sweden HLA typing market, by application
      • 8.3.8.8 Sweden HLA typing market, by End-user
      • 8.3.8.9 Sweden HLA typing market, by technique
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Target Disease Prevalence
      • 8.3.9.3 Competitive Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
      • 8.3.9.6 Norway HLA typing market, by product
      • 8.3.9.7 Norway HLA typing market, by application
      • 8.3.9.8 Norway HLA typing market, by End-user
      • 8.3.9.9 Norway HLA typing market, by technique
  • 8.4 Asia Pacific
    • 8.4.1 SWOT Analysis
      • 8.4.1.1 Asia Pacific HLA typing market, by product
      • 8.4.1.2 Asia Pacific HLA typing market, by application
      • 8.4.1.3 Asia Pacific HLA typing market, by End-user
      • 8.4.1.4 Asia Pacific HLA typing market, by technique
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Target Disease Prevalence
      • 8.4.2.3 Competitive Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
      • 8.4.2.6 Japan HLA typing market, by product
      • 8.4.2.7 Japan HLA typing market, by application
      • 8.4.2.8 Japan HLA typing market, by End-user
      • 8.4.2.9 Japan HLA typing market, by technique
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 Target Disease Prevalence
      • 8.4.3.3 Competitive Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
      • 8.4.3.6 China HLA typing market, by product
      • 8.4.3.7 China HLA typing market, by application
      • 8.4.3.8 China HLA typing market, by End-user
      • 8.4.3.9 China HLA typing market, by technique
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 Target Disease Prevalence
      • 8.4.4.3 Competitive Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
      • 8.4.4.6 India HLA typing market, by product
      • 8.4.4.7 India HLA typing market, by application
      • 8.4.4.8 India HLA typing market, by End-user
      • 8.4.4.9 India HLA typing market, by technique
    • 8.4.5 South Korea
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Target Disease Prevalence
      • 8.4.5.3 Competitive Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
      • 8.4.5.6 South Korea HLA typing market, by product
      • 8.4.5.7 South Korea HLA typing market, by application
      • 8.4.5.8 South Korea HLA typing market, by End-user
      • 8.4.5.9 South Korea HLA typing market, by technique
    • 8.4.6 Australia
      • 8.3.9.1 Key Country Dynamics
      • 8.4.6.2 Target Disease Prevalence
      • 8.4.6.3 Competitive Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
      • 8.4.6.6 Australia HLA typing market, by product
      • 8.4.6.7 Australia HLA typing market, by application
      • 8.4.6.8 Australia HLA typing market, by End-user
      • 8.4.6.9 Australia HLA typing market, by technique
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Target Disease Prevalence
      • 8.4.7.3 Competitive Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
      • 8.4.7.6 Thailand HLA typing market, by product
      • 8.4.7.7 Thailand HLA typing market, by application
      • 8.4.7.8 Thailand HLA typing market, by End-user
      • 8.4.7.9 Thailand HLA typing market, by technique
  • 8.5 Latin America
    • 8.5.1 SWOT Analysis
      • 8.5.1.1 Latin America HLA typing market, by product
      • 8.5.1.2 Latin America HLA typing market, by application
      • 8.5.1.3 Latin America HLA typing market, by End-user
      • 8.5.1.4 Latin America HLA typing market, by technique
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Target Disease Prevalence
      • 8.5.2.3 Competitive Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
      • 8.5.2.6 Brazil HLA typing market, by product
      • 8.5.2.7 Brazil HLA typing market, by application
      • 8.5.2.8 Brazil HLA typing market, by End-user
      • 8.5.2.9 Brazil HLA typing market, by technique
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Target Disease Prevalence
      • 8.5.3.3 Competitive Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
      • 8.5.3.6 Mexico HLA typing market, by product
      • 8.5.3.7 Mexico HLA typing market, by application
      • 8.5.3.8 Mexico HLA typing market, by End-user
      • 8.5.3.9 Mexico HLA typing market, by technique
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Target Disease Prevalence
      • 8.5.4.3 Competitive Scenario
      • 8.5.4.4 Regulatory Framework
      • 8.5.4.5 Reimbursement Scenario
      • 8.5.4.6 Argentina HLA typing market, by product
      • 8.5.4.7 Argentina HLA typing market, by application
      • 8.5.4.8 Argentina HLA typing market, by End-user
      • 8.5.4.9 Argentina HLA typing market, by technique
  • 8.6 MEA
    • 8.6.1 SWOT Analysis
      • 8.6.1.1 MEA HLA typing market, by product
      • 8.6.1.2 MEA HLA typing market, by application
      • 8.6.1.3 MEA HLA typing market, by End-user
      • 8.6.1.4 MEA HLA typing market, by technique
    • 8.6.2 South Africa
      • 8.6.4.1 Key Country Dynamics
      • 8.6.2.2 Target Disease Prevalence
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
      • 8.6.2.6 Argentina HLA typing market, by product
      • 8.6.2.7 Argentina HLA typing market, by application
      • 8.6.2.8 Argentina HLA typing market, by End-user
      • 8.6.2.9 Argentina HLA typing market, by technique
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Target Disease Prevalence
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
      • 8.6.3.6 Saudi Arabia HLA typing market, by product
      • 8.6.3.7 Saudi Arabia HLA typing market, by application
      • 8.6.3.8 Saudi Arabia HLA typing market, by End-user
      • 8.6.3.9 Saudi Arabia HLA typing market, by technique
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Target Disease Prevalence
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
      • 8.6.4.6 UAE HLA typing market, by product
      • 8.6.4.7 UAE HLA typing market, by application
      • 8.6.4.8 UAE HLA typing market, by End-user
      • 8.6.4.9 UAE HLA typing market, by technique
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Target Disease Prevalence
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
      • 8.6.5.6 Kuwait HLA typing market, by product
      • 8.6.5.7 Kuwait HLA typing market, by application
      • 8.6.5.8 Kuwait HLA typing market, by End-user
      • 8.6.5.9 Kuwait HLA typing market, by technique

Chapter 9 Competitive Landscape

  • 9.1 Participant's overview
  • 9.2 Financial performance
  • 9.3 Participant categorization
    • 9.3.1 Market leaders
      • 9.3.1.1 HLA typing market share analysis, 2022
      • 9.3.1.2 Company profiles
      • 9.3.1.2.1 Thermo Fisher Scientific Inc.
      • 9.3.1.2.2 Bio-Rad Laboratories Inc.
      • 9.3.1.2.3 Qiagen N.V.
      • 9.3.1.2.4 Omixon Inc.
      • 9.3.1.2.5 GenDx
      • 9.3.1.2.6 Illumina Inc.
      • 9.3.1.2.7 TBG Diagnostics Limited
      • 9.3.1.2.8 Dickinson and Company
      • 9.3.1.2.9 Takara Bio Inc.
      • 9.3.1.2.10 F. Hoffman-La Roche Limited
      • 9.3.1.2.11 Pacific Biosciences
    • 9.3.2 Strategy mapping
      • 9.3.2.1 Expansion
      • 9.3.2.2 Acquisition
      • 9.3.2.3 Collaborations
      • 9.3.2.4 Product/service launch
      • 9.3.2.5 Partnerships
      • 9.3.2.6 Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 6 Global HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 7 Global HLA typing Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 12 North America HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 13 U.S. HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 16 U.S. HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 17 Canada HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 20 Canada HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 21 Europe HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Europe HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Europe HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 25 Europe HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 26 Germany HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Germany HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 29 Germany HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 30 U.K. HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 U.K. HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 U.K. HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 33 U.K. HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 34 France HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 France HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 France HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 37 France HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 38 Italy HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Italy HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 41 Italy HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 42 Spain HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Spain HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Spain HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 45 Spain HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 46 Denmark HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Denmark HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 49 Denmark HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 50 Sweden HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Sweden HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 53 Sweden HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 54 Norway HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Norway HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Norway HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 57 Norway HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 63 China HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 China HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 China HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 66 China HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 67 Japan HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Japan HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Japan HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 70 Japan HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 71 India HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 India HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 India HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 74 India HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 75 South Korea HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 South Korea HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 South Korea HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 78 South Korea HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 79 Australia HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 Australia HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Australia HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 82 Australia HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 83 Thailand HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Thailand HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Thailand HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 86 Thailand HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 87 Latin America HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Latin America HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 91 Latin America HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 92 Brazil HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Brazil HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 95 Brazil HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 96 Mexico HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Mexico HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Mexico HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 99 Mexico HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 100 Argentina HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 103 Argentina HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 109 South Africa HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 112 South Africa HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 117 UAE HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 120 UAE HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 121 Kuwait HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 124 Kuwait HLA typing Market, End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 HLA typing Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global HLA typing Market: Product Movement Analysis
  • Fig. 17 Global HLA typing Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global HLA typing Market, for Reagents & Consumables, 2018 - 2030 (USD Million)
  • Fig. 19 Global HLA typing Market, for Software & Services, 2018 - 2030 (USD Million)
  • Fig. 20 Global HLA typing Market: Application Movement Analysis
  • Fig. 21 Global HLA typing Market, for Diagnosis, 2018 - 2030 (USD Million)
  • Fig. 22 Global HLA typing Market, for Research, 2018 - 2030 (USD Million)
  • Fig. 23 Global HLA typing Market: Technique Movement Analysis
  • Fig. 24 Global HLA typing Market, for Molecular Assay, 2018 - 2030 (USD Million)
  • Fig. 25 Global HLA typing Market, for Sequenced-based Molecular Assay, 2018 - 2030 (USD Million)
  • Fig. 26 Global HLA typing Market, for Non-Molecular Assay, 2018 - 2030 (USD Million)
  • Fig. 27 Global HLA typing Market: End Use Movement Analysis
  • Fig. 28 Global HLA typing Market, for Commercial Service Providers, 2018 - 2030 (USD Million)
  • Fig. 29 Global HLA typing Market, for Hospitals and Transplant Centers, 2018 - 2030 (USD Million)
  • Fig. 30 Global HLA typing Market, for Research Labs & Academic Institutes, 2018 - 2030 (USD Million)
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Outlook, 2022 & 2030
  • Fig. 33 Global HLA typing Market: Region Movement Analysis
  • Fig. 34 North America HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.K. HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 40 France HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 48 China HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 49 India HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait HLA typing Market, 2018 - 2030 (USD Million)